题目
(b) Seymour offers health-related information services through a wholly-owned subsidiary, Aragon Co. Goodwill of
$1·8 million recognised on the purchase of Aragon in October 2004 is not amortised but included at cost in the
consolidated balance sheet. At 30 September 2006 Seymour’s investment in Aragon is shown at cost,
$4·5 million, in its separate financial statements.
Aragon’s draft financial statements for the year ended 30 September 2006 show a loss before taxation of
$0·6 million (2005 – $0·5 million loss) and total assets of $4·9 million (2005 – $5·7 million). The notes to
Aragon’s financial statements disclose that they have been prepared on a going concern basis that assumes that
Seymour will continue to provide financial support. (7 marks)
Required:
For each of the above issues:
(i) comment on the matters that you should consider; and
(ii) state the audit evidence that you should expect to find,
in undertaking your review of the audit working papers and financial statements of Seymour Co for the year ended
30 September 2006.
NOTE: The mark allocation is shown against each of the three issues.
第1题
medical innovations designed to improve the quality of life. (Proprietary foods are marketed under and protected by
registered names.) The draft consolidated financial statements for the year ended 30 September 2006 show revenue
of $74·4 million (2005 – $69·2 million), profit before taxation of $13·2 million (2005 – $15·8 million) and total
assets of $53·3 million (2005 – $40·5 million).
The following issues arising during the final audit have been noted on a schedule of points for your attention:
(a) In 2001, Seymour had been awarded a 20-year patent on a new drug, Tournose, that was also approved for
food use. The drug had been developed at a cost of $4 million which is being amortised over the life of the
patent. The patent cost $11,600. In September 2006 a competitor announced the successful completion of
preliminary trials on an alternative drug with the same beneficial properties as Tournose. The alternative drug is
expected to be readily available in two years time. (7 marks)
Required:
For each of the above issues:
(i) comment on the matters that you should consider; and
(ii) state the audit evidence that you should expect to find,
in undertaking your review of the audit working papers and financial statements of Seymour Co for the year ended
30 September 2006.
NOTE: The mark allocation is shown against each of the three issues.
第2题
he late 30s.
A、render
B、professional
C、indifferent
D、indebted
E、regarding
F、concern
G、fascinate
H、pursue
I、favorable
J、the case
第3题
(c) In November 2006 Seymour announced the recall and discontinuation of a range of petcare products. The
product recall was prompted by the high level of customer returns due to claims of poor quality. For the year to
30 September 2006, the product range represented $8·9 million of consolidated revenue (2005 – $9·6 million)
and $1·3 million loss before tax (2005 – $0·4 million profit before tax). The results of the ‘petcare’ operations
are disclosed separately on the face of the income statement. (6 marks)
Required:
For each of the above issues:
(i) comment on the matters that you should consider; and
(ii) state the audit evidence that you should expect to find,
in undertaking your review of the audit working papers and financial statements of Seymour Co for the year ended
30 September 2006.
NOTE: The mark allocation is shown against each of the three issues.
第4题
第5题
A.Wood,Bruner & Ross
B.Vygotsky
C.James Ashe
D.Jerome Seymour Bruner
第6题
A.Wood,Bruner & Ross
B.Vygotsky
C.James Asher
D.Jerome Seymour Bruner
第7题
A.Wood,Bruner & Ross
B.Vygotsky
C.James Ashe
D.Jerome Seymour Bruner
为了保护您的账号安全,请在“赏学吧”公众号进行验证,点击“官网服务”-“账号验证”后输入验证码“”完成验证,验证成功后方可继续查看答案!